Contra Brooks, the Barnett-Saliba-Walker analysis was not intended to justify the government’s acting as a payer-of-last-resort. A totally free market in kidneys—one without government subsides and without the prohibition of sale and purchase of kidneys, but also without other currently imposed supply-restricting interventions—would meet Brooks’s efficiency concerns and would be more equitable than the current system.

EconomyFDA and Drug RegulationFree Market EconomicsHealth and Healthcare
Other Independent Review articles by William Barnett II
Winter 2000/01 A Free Market in Kidneys: Efficient and Equitable
Other Independent Review articles by Michael Saliba
Winter 2000/01 A Free Market in Kidneys: Efficient and Equitable
Other Independent Review articles by Deborah Walker
Winter 2000/01 A Free Market in Kidneys: Efficient and Equitable